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could be expanded in monolayer until passage 5 without loss of
their undifferentiated phenotypes.
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SUB-CHONDRAL NACRE IMPLANT IN ARTICULAR ZONE IN
SHEEP KNEE
M. Rousseau1, O. Delattre2, P. Netter1, P. Gillet1, E. Lopez3
1Nancy Univ., Vandoeuvre les Nancy, France; 2CHU Fort de
France, Fort de France, France; 3Muséum Natl. d’Histoire
Naturelle, Paris, France
Purpose: One of the major challenges of orthopedic surgery is the
restoration of lost bone and cartilage using biomaterials. Despite
recent progress in this area, there is clearly todate no biomaterial
than can satisfy all the prerequired. Mother of pearl (or nacre)
is a composite natural biomaterial, source of bioactive molecules
having biological activities on cells of the bone lineage and on skin
ﬁbroblasts and keratinocytes. This study is designed to identify
the behaviour of nacre in subchondral bone area in sheep knee.
To this end we followed-up the biointegration of an osteochondral
nacreous implant histologically and radiologically.
Methods: We implanted nacre blocks in sheep trochlea, by re-
placing the half of the femoral trochlea. The subchondral area of
the implant was at the level of the sub-chondral bone level not
at the cartilage one. For comparison we used complete cartilage
resection until sub-chondral bone.
After implantation sheep were killed after 3, 6 and 9 months.
Histological and radiological evaluations were done on the carti-
lage/nacre interface without decalciﬁcation.
Results: Nacre implants were well tolerated without any synovial
reaction. We observed centripetal regrowth of new cartilage in 6/9
cases after 3 months, and radiography showed osteointegration.
On the resection sample no cartilage regrowth was observed,
but formation of a thin layer of ﬁbrous tissue was noted. After 6
months a new cartilage covered totally the nacre implant. Chondral
resurfacing of the endo-articular face was observed after 9 months
and cartilaginous islets of hyaline cartilage were observed in deep
layers demonstrating the chondroinduction potentialities of nacre.
Conclusions: In conclusion, nacre presents chondroinductive po-
tentialities as sub-chondral implant for cartilage regrowth. The
surface of sub-chondral implants of nacre in articular zones was
not resorbed, but became covered with ﬁbrocartilaginous tissue
that contained islets of hyaline cartilage in the deep layers. Finally
this study demonstrates the potential of nacreous biomaterial able
to stimulate cartilage repair.
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THE USE OF BONE MATRIX GELATIN AS A
TISSUE-INDUCTIVE SCAFFOLD FOR THE IN VITRO
CONSTRUCTION OF HUMAN CARTILAGE WITH ADJACENT
BONE SEGMENTS
J. Cao1, M. Lu1, F. Liu1, Q. Fu1, J. Liu1, S. Li1, J. Chen1,
A. Zhang1, Z. Zhang1, J. Zhu1, C.E. Hughes2, B. Caterson2
1Xi’an Jiaotong Univ., Xi’an, China; 2Cardiff Univ., Cardiff, United
Kingdom
Purpose: To use Bone Matrix Gelatin (BMG) as a scaffold along
with human embryo chondrocytes as seeds for the in vitro tissue
engineering of cartilage & bone ‘limb’ grafts.
Methods: Bone matrix gelatin (BMG) was prepared from cancel-
lous bones of adult rabbits using previously published procedures
(Li et al. J Zhejiang Univ Sci B. 2008, 9(1): 22-33). The BMG was
cut into a cylinder (5mm wide x 2mm deep) and sterilized with
ethylene oxide. Human chondrocytes were isolated from 10th-
week human embryo cartilage anlagen by sequential enzyme
treatments. One million Passage 2 cells were seeded onto BMG
grafts and cultured for 3 weeks in vitro. The culture media was
changed every 3 days. After 3 weeks, the engineered tissue was
ﬁxed, embedded, and cut into 14μm slices for histological anal-
ysis. Slides were stained with hematoxylin & eosin (H&E) and
toluidine blue. Immunohistochemical analysis was used to detect
the expression of collagen types I, II & X and aggrecan.
Results: H&E staining indicated that the engineered grafts were
very similar to an articular cartilage above an epiphyseal growth
plate with developing bone in vivo. The tissue most distal to
the graft was morphologically similar to bone; i.e. bone trabeculae
were observed. The cartilage layer nearest the BMG was thick and
exhibited different zonal layers of cells organized similar to that
seen in early articular cartilage above a developing growth plate
(resting layer, upper and lower proliferative layer and hypertrophic
layer). In the deep bone-like trabecula layer, osteoblasts and
bone marrow cells were observed. Immunohistochemical analysis
indicated that the presence of aggrecan and type II collagen
expression in the cartilaginous regions. Type I collagen expression
was observed in the deeper bone-like regions and type X collagen
expression was observed in the hypertrophic-like zone.
Conclusions: This study has demonstrated that harvesting cells
from the proximal cartilaginous anlagen regions of the developing
human limb and culturing these with de-mineralized BMG scaf-
folds can cause a recapitulation of embryonic bone development in
vitro; i.e. the potential production tissue engineered articular carti-
lage, growth plate and bone with trabeculae using in vitro culture
systems. These results suggest that cells in the early developing
cartilage anlagen are pre-programmed for their phenotypic out-
come in limb development and these programming signals are
maintained in the in vitro cultures. They also illustrate the potential
for using tissue engineering applications for the reconstruction of
whole limb segmentss for use in orthopaedic medicine.
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EVALUATION OF ACCELL™ AND LIPOFECTAMINE™ 2000
TO DELIVER SMALL INTERFERING RNA MOLECULES TO
FULL-THICKNESS CARTILAGE EXPLANTS
K.S. Santangelo, S.S. Dougherty, A.L. Bertone
The Ohio State Univ., Columbus, OH
Purpose: Osteoarthritis (OA) is marked by continual degradation
of cartilage and interruption of overall joint homeostasis. Although
the in vivo pathogenesis of the disease remains unclear, RNA in-
terference (RNAi) provides a tool that may characterize the molec-
ular causes of OA and offer new treatment tactics. Importantly,
RNAi relies as much on successful delivery of small interfering
RNA (siRNA) to cells as it does on identiﬁcation of an effective
knockdown sequence. Cartilage poses a unique challenge to in
situ delivery of siRNAs given its distinctive architecture and avas-
cular nature. The aim of our study was to identify the transfection
reagent that offered the greatest delivery of siRNA molecules
to chondrocytes, using both monolayer culture and full-thickness
cartilage. Our hypothesis was that Accell™ siRNA, which has
been modiﬁed for use without additional reagents, would transfect
a higher percentage of chondrocytes in intact tissue relative to
Lipofectamine™ 2000.
Methods: Chondrocytes, both isolated and in full-thickness carti-
lage, were harvested from a laboratory animal model of OA and
a large animal model noted for its similarity to human cartilage.
Monolayer cells and uniform explants were exposed to transfec-
tion complexes according to manufacturers’ protocols. Fluorescent
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siRNA duplexes allowed the quantiﬁcation of transfected cells via
ﬂow cytometry and direct visualization of the depth of in situ
transfection by ﬂuorescent microscopy.
Results: Flow cytometry revealed that >90% of monolayer
chondrocytes were transfected by Accell™ and Lipofectamine™
2000. In explants, only Accell™ reached >50% transfection
efﬁciency, while Lipofectamine™ 2000 exposed chondrocytes
achieved <25%. Correspondingly, microscopy demonstrated that
only Accell™ treated guinea pig (Figure 1, left column) and equine
(Figure 1, middle column) cartilage contained ﬂuorescent cells
throughout all zones; Lipofectamine™ 2000 transfected chondro-
cytes were restricted to explant surfaces (Figure 1, right column;
equine explant represented).
Figure 1
Conclusions: This study showed that, although transfection of
chondrocytes in monolayer can be achieved with both reagents,
only Accell™ can accomplish full-thickness transfection of ex-
plants. Future investigations will demonstrate the effective knock-
down that can be attained using Accell™ in joint tissue in vitro and
in vivo.
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WNT-BETA-CATENIN SIGNALING IS UPREGULATED IN ANK
MOUSE CHONDROCYTES
F. Las Heras1, R.D. Inman2, F.W. Tsui2, K.P. Pritzker3
1Mount Sinai Hosp., Toronto Western Res. Inst., Univ. of Toronto,
Toronto, ON, Canada; 2Toronto Western Res. Inst., Univ. of
Toronto, Toronto, ON, Canada; 3Mount Sinai Hosp., Univ. of
Toronto, Toronto, ON, Canada
Purpose: Wnt-β-catenin signaling activation has been observed in
cartilage and synovium of osteoarthritis, a disease associated with
abnormal articular chondrocyte hypertrophy. The mutant ank/ank
mouse is a model of chondrocyte hypertrophy and osteophyte
formation. The aim of this study is to demonstrate the roles of
the Wnt pathway in the ank mouse, by studying the distribution of
β-catenin in articular and epiphyseal cartilage as well as synovium.
Methods: Decalciﬁed parafﬁn embedded 5 μm sections were
obtained from knee joints from 12 mice, 3 ank/ank and 3 controls
each at 8 and 12 weeks of age respectively. The sections were
stained with hematoxylin and eosin (H&E). Immunohistochemical
studies were performed using antibodies for rabbit anti-mouse
polyclonal anti-beta-catenin.
Results: As we previously reported, H&E staining revealed hy-
pertrophic chondrocytes in the superﬁcial articular cartilage of ank
mice, a ﬁnding not observed in control mice. Immunohistochem-
istry for β-catenin antibody in 8 week-old ank mice revealed intense
staining in both articular and epiphyseal chondrocytes from all the
layers, showing nuclear translocation. Marked β-catenin cytoplas-
mic staining of the synovial lining of ank mice was also noted. In
contrast, control mice at 8 weeks reveal less intense cytoplasmic
and membrane staining of all the layers of the articular cartilage,
with absence of nuclear staining. The epiphyseal intercellular ma-
trix from 8 week-old ank mice stained intensively, predominantly in
the proliferating and prehypertrophic zones. In contrast, in epiphy-
seal cartilage matrix from control mice, β-catenin matrix staining
was much weaker than that observed in the ank mouse. At 12
weeks, articular chondrocytes from ank mice continue to reveal
strong cytoplasmic and nuclear staining for β-catenin in all lay-
ers of the articular cartilage (Figure 1). This strong staining was
also observed in the epiphyseal chondrocytes of ank mouse, in
the cartilage matrix, as well as in synovial lining cells. Articular
chondrocytes from the superﬁcial layer of control mice showed al-
most no staining for β-catenin, with only focal membrane staining
in chondrocytes from the deep layer. No β-catenin staining was
noted in the epiphyseal chondrocytes, matrix or synovial lining
cells of control mice at 12 weeks (Figure 2).
Figure 1. Ank/ank proximal tibial
cartilage, 12 weeks
Figure 2. Wild type proximal tibial
cartilage, 12 weeks
Conclusions: Our study showed increased cytoplasmic and nu-
clear immunostaining for β-catenin at 8 weeks in ank mice chon-
drocytes when compared to normal, revealing high levels of free
cytoplasmic β-catenin in ank mice. This increase was observed in
all the layers of the articular and epiphyseal cartilage, as well as in
the matrix and synovium. Increased β-catenin immunohistochemi-
cal levels were still persistent in articular and epiphyseal cartilage
in ank mice at 12 weeks, whereas 12 week control mice showed
only minimal activation in both cartilaginous tissues and synovium.
The results demonstrate increased Wnt-β-catenin activation in ank
mice chondrocytes and its persistence with age. We suggest that
Wnt-β-catenin signaling activation is a common process for the
pathogenesis of chondrocyte hypertrophy, both in ank mouse and
in osteoarthritis. This reinforces the ank mouse as a model to
study chondrocyte hypertrophy in osteoarthritis.
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ADIPONECTIN AS A CATABOLIC FACTOR IN OA.
ADIPONECTIN CORRELATES WITH CIRCULATING COMP
AND MMP-3, AND INCREASES PRODUCTION OF MMP-3,
NITRIC OXIDE AND IL-6 IN HUMAN OA CARTILAGE
K. Vuolteenaho1, S. Juslin1, R. Nieminen1, T. Moilanen2,
E. Moilanen1
1The Immunopharmacology Res. Group, Med. Sch., Univ. of
Tampere and Res. Unit, Tampere Univ. Hosp., Tampere, Finland;
2Coxa Hosp. for Joint Replacement and The
Immunopharmacology Res. Group, Med. Sch., Univ. of Tampere,
Tampere, Finland
Purpose: Adiponectin is an adipokine produced by adipose tissue
and known to regulate a number of metabolic processes includ-
